Bank of Montreal’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Bank of Montreal’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-9,000	Closed	-$218K	–	4938
2020 Q1	$218K	Buy	+9,000	New	+$251K	﹤0.01%	2295
2014 Q2	–	Sell	-121,600	Closed	-$1.42M	–	4880
2014 Q1	$1.42M	Buy	121,600 +101,500	+505%	+$1.72M	﹤0.01%	1491
2013 Q4	$355K	Buy	+20,100	New	+$338K	﹤0.01%	1974

Bank of Montreal's MNTA Position: Q4 2020 in Review

Bank of Montreal sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 8,429 shares — an estimated $442K sold.

Bank of Montreal first reported a position in MNTA in Q2 2013 and held it in 28 quarters. The position peaked at $1.49M in Q3 2018. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

Bank of Montreal reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Bank of Montreal sold 8,429 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $442K.
Bank of Montreal first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 28 quarters.
Bank of Montreal's Momenta Pharmaceuticals, Inc. position peaked at $1.49M in Q3 2018.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Bank of Montreal's 13F filing for Q4 2020, filed 12 Feb 2021.